1. Signaling Pathways
  2. GPCR/G Protein
    Immunology/Inflammation
    Neuronal Signaling
  3. Histamine Receptor
  4. H4 Receptor Isoform

H4 Receptor

Histamine H4 receptor (H4R) is a G protein-coupled receptor predominantly expressed in hematopoietic and immune cells, where it regulates immune cell trafficking, chemotaxis, and inflammatory responses[1][2][3]. Mechanistically, H4R activation promotes calcium mobilization and directional migration of mast cells, eosinophils, macrophages, dendritic cells, and T cells, positioning the receptor as a key regulator of histamine-dependent immune signaling pathways[4][5][6][7]. Through its effects on cytokine, chemokine, and adhesion molecule regulation, H4R contributes to leukocyte recruitment and amplification of inflammatory processes in allergic and immune-mediated conditions[2][6][8]. In disease models, H4R has been implicated in allergic airway inflammation, autoimmune disorders, pruritic skin diseases, and chronic inflammatory conditions, where pharmacological blockade of the receptor reduces inflammatory responses and improves disease outcomes[8][9][10][11]. Compared with related histamine receptor isoforms, H4R exhibits a distinct expression profile that is concentrated in immune and inflammatory cell populations, whereas H1R primarily mediates allergic symptoms, H2R regulates gastric acid secretion and immune modulation, and H3R functions predominantly in the nervous system[1][3][12]. This immune-selective distribution makes H4R particularly valuable for investigating inflammatory mechanisms and immune-cell migration[3][12]. For experimental applications, selective H4R agonists such as 4-methylhistamine and antagonists including JNJ7777120 have been widely used to characterize receptor-specific signaling and evaluate therapeutic modulation of inflammation in preclinical models[10][13][14].

References:

H4 Receptor 관련 제품 (25):

Cat. No. 상품명 효과 Purity
  • HY-101189B
    JNJ-39758979 dihydrochloride
    Antagonist
    JNJ-39758979 dihydrochloride is a selective, orally active, and high-affinity histamine H4 receptor antagonist, with Kis of 12.5, 5.3, and 25 nM for human, mouse, and monkey histamine H4 receptor, respectively. JNJ-39758979 dihydrochloride functionally antagonizes histamine-induced cAMP inhibition with a pA2 of 7.9 in transfected cells. JNJ-39758979 dihydrochloride shows good anti-inflammatory and antipruritic activity.
  • HY-W580721
    4-Methylhistamine
    Agonist
    4-Methylhistamine is a potent and selective agonist of histamine 4 receptor (H4R) with a Ki of 50 nM. 4-Methylhistamine has a >100-fold selectivity for the hH4R over the other histamine receptor subtypes. 4-Methylhistamine can potently activate the hH4R (pEC50 = 7.4). 4-Methylhistamine can be used for the researches of cancer, inflammation and immunology, such as lung cancer and skin inflammation.
  • HY-14517
    H3R antagonist 5
    Agonist
    H3R antagonist 5 (Compound 1b) is a selective histamine H3 receptor inverse agonist with a IC50 of 0.54 nM and the ability to cross the blood-brain barrier. H3R antagonist 5 can be used in central nervous system-related research.
  • HY-119279
    VUF 10214
    VUF 10214 is a H4 receptor ligand with a pKi of 8.25. VUF 10214 exhibits significant anti-inflammatory activity in a carrageenan-induced paw edema rat model and can be used for research in the field of inflammatory diseases.
  • HY-120531
    UR-PI376
    Modulator
    UR-PI376 is a potent and selective histamine H4 receptor (H4R) agonist with a pEC50 value of 7.47. UR-PI376 shows negligible hH1R and hH2R activities and moderate inverse agonistic activity at the hH3R.